Sterilisation assembly

US12440589B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12440589-B2
Application numberUS-202017602831-A
CountryUS
Kind codeB2
Filing dateApr 9, 2020
Priority dateApr 12, 2019
Publication dateOct 14, 2025
Grant dateOct 14, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

There is provided a sterilisation assembly for a molecular diagnostic assay analyse. The assembly comprising: an enclosure having a passage therethrough, the passage being arranged in use to allow an assay sample set to pass through the enclosure, the enclosure defining a barrier adapted in use to restrict fluid communication across the enclosure to communication through the passage; and a decontaminator located within the passage, the decontaminator is arranged in use to sterilise contamination in the passage.

First claim

Opening claim text (preview).

The invention claimed is: 1. A sterilisation assembly for a molecular diagnostic assay analyser, the sterilisation assembly comprising: an enclosure having a passage therethrough, the passage to allow an assay sample set to pass through the enclosure, the enclosure defining a barrier to restrict fluid communication across the enclosure to communication through the passage; and a decontaminator located within the passage, the decontaminator to sterilise contamination in the passage; a moveable stage to removably mount at least one sample; wherein the moveable stage is to move along a path through the passage, the decontaminator being attached to the moveable stage. 2. The sterilisation assembly according to claim 1 , wherein the passage is defined by a tunnel forming part of the enclosure. 3. The sterilisation assembly according to claim 2 , wherein an inwardly facing surface of the tunnel is polyurethane. 4. The sterilisation assembly according to claim 1 , further comprising an elevated platform in the passage, the moveable stage being connected to an electrical cable, the cable passing under the elevated platform. 5. The sterilisation assembly according to claim 4 , wherein the cable has a swivel joint. 6. The sterilisation assembly according to claim 1 , wherein the moveable stage is arranged to move along a rail. 7. The sterilisation assembly according to claim 1 , further comprising a drive mechanism arranged to move the moveable stage. 8. The sterilisation assembly according to claim 7 , wherein the drive mechanism comprises a belt to which the moveable stage is attached. 9. The sterilisation assembly according to claim 1 , wherein the decontaminator is attached to the moveable stage. 10. The sterilisation assembly according to claim 9 , wherein the moveable stage is orientated with at least one side crossing the path, the decontaminator being attached at a side of the moveable stage crossing the path. 11. The sterilisation assembly according to claim 10 , wherein the moveable stage is moveable between a first position and a second position, when the moveable stage is located at the first position, the side of the moveable stage to which the decontaminator is attached is distal to the second position. 12. The sterilisation assembly according to claim 1 , wherein the passage is accessible by one or more openings, each opening having an area of less than or equal to the area of an upper surface of the moveable stage. 13. The sterilisation assembly according to claim 1 , wherein the passage includes at least one turn. 14. The sterilisation assembly according to claim 13 , wherein the turn changes the direction of the passage by an angle greater than an acute angle. 15. The sterilisation assembly according to claim 14 , wherein the turn is U shaped. 16. The sterilisation assembly according to claim 1 , further comprising a pump arranged to move gas within the passage. 17. The sterilisation assembly according to claim 16 , wherein the enclosure includes an outlet connected to the pump. 18. The sterilisation assembly according to claim 17 , wherein the outlet comprises a filter. 19. The sterilisation assembly according to claim 16 , wherein the enclosure includes an inlet connected to the pump. 20. The sterilisation assembly according to claim 19 , wherein the inlet comprises a filter. 21. The sterilisation assembly according to claim 16 , wherein the pump comprises at least one fan. 22. The sterilisation assembly according to claim 1 , wherein the decontaminator is arranged to produce electromagnetic radiation to provide radiation sterilisation. 23. The sterilisation assembly according to claim 22 , wherein the electromagnetic radiation is Ultraviolet C (UVC) radiation.

Assignees

Inventors

Classifications

  • Analysers with modular structure · CPC title

  • comprising robots or similar manipulators (robots per se B25J) · CPC title

  • Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps · CPC title

  • Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor · CPC title

  • A61L2/10Primary

    Ultraviolet [UV] radiation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12440589B2 cover?
There is provided a sterilisation assembly for a molecular diagnostic assay analyse. The assembly comprising: an enclosure having a passage therethrough, the passage being arranged in use to allow an assay sample set to pass through the enclosure, the enclosure defining a barrier adapted in use to restrict fluid communication across the enclosure to communication through the passage; and a deco…
Who is the assignee on this patent?
Randox Laboratories Ltd
What technology area does this patent fall under?
Primary CPC classification A61L2/10. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).